Pioglitazone Tablets USP, 45 mg, 500 count bottles, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ -- NDC…
Reason Superpotent and Failed Tablet/Capsule Specifications
9 FDA recalls mention Pioglitazone. The most recent are listed below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Pioglitazone.
Reason Superpotent and Failed Tablet/Capsule Specifications
Reason Subpotent Drug: Out of specification assay result, below specification, for two lots of Pioglitazone And Metformin Hydrochloride Tablets.
Reason Superpotent
Reason Defective Delivery System: tablets may be missing, in whole or in part, the laser drilled holes on the metformin core of the Actoplus met XR tablets.
Reason Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.
Reason Failed Dissolution Specifications
Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they…
Reason Labeling: Label Mixup: PIOGLITAZONE, Tablet, 15 mg may have potentially been mislabeled as one of the following drugs: LACTASE ENZYME, Tablet, 3000…
Reason Labeling: Label Mixup: PIOGLITAZONE HCL, Tablet, 15 mg may have potentially been mislabeled as one of the following drugs: DOXYCYCLINE MONOHYDRATE…
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.